Hopp til hovedinnhold

Epileptiske encefalopatier

Sist oppdatert: Sist revidert:
Sist revidert av:
  1. Lund C1, Brodtkorb E, Nakken KO.. Lennox-Gastaut syndrome--course and treatment.. Tidsskr Nor Laegeforen. 2011; Jan 7;131(1):: 24-7. pmid: 21233883 PubMed  
  2. Knupp KG, Scheffer IE, Ceulemans B, Sullivan JE, Nickels KC, Lagae L, Guerrini R, Zuberi SM, Nabbout R, Riney K, Shore S, Agarwal A, Lock M, Farfel GM, Galer BS, Gammaitoni AR, Davis R, Gil-Nagel A. Efficacy and Safety of Fenfluramine for the Treatment of Seizures Associated With Lennox-Gastaut Syndrome: A Randomized Clinical Trial. JAMA Neurol. 2022 Jun 1;79(6):554-564. doi: 10.1001/jamaneurol.2022.0829. PMID: 35499850 PubMed  
  3. Lund C, Bremer A, Lossius MI, Selmer KK, Brodtkorb E, Nakken KO. Dravet syndrome as a cause of epilepsy and learning disability.. Tidsskr Nor Laegeforen. 2012; 2012 Jan 10;132(1):44-7. pmid:22240828 PubMed  
  4. Bremer A1, Lossius MI, Nakken KO. Dravet syndrome--considerable delay in making the diagnosis. Acta Neurol Scand. 2012; May;125(5): 359-62. pmid:22050316 PubMed  
  5. Devinsky O, Cross JH, Laux L, Marsh E, Miller I, Nabbout R, Scheffer IE, Thiele EA, Wright S; Cannabidiol in Dravet Syndrome Study Group. Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome. N Engl J Med. 2017 May 25;376(21):2011-2020. PMID: 28538134 PubMed  
  6. Tuft M, Årva M, Bjørnvold M, Wilson JA, Nakken KO. Landau-Kleffner syndrome Tidsskr Nor Laegeforen. 2015 Dec 1;135(22):2061-4. PMID: 26627294 PubMed  
  7. Kramer U, Sagi L, Goldberg-Stern H, Zelnik N, Nissenkorn A, Ben-Zeev B. Clinical spectrum and medical treatment of children with electrical status epilepticus in sleep (ESES). Epilepsia. 2009 Jun;50(6):1517-24. PMID: 19054417 PubMed  
  8. Sasongko TH, Ismail NF, Zabidi-Hussin Z. Rapamycin and rapalogs for tuberous sclerosis complex. Cochrane Database Syst Rev. 2016 Jul 13;7:CD011272 . pmid:27409709 PubMed  
  9. Brandt-Hansen P1, Solhoff R.. Tuberous sclerosis complex.. Tidsskr Nor Laegeforen. 2007; Mar 29;127(7):.: 870-3. pmid:17435807 PubMed  
  10. Neul JL1, Kaufmann WE, Glaze DG, Christodoulou J, Clarke AJ, Bahi-Buisson N, Leonard H, Bailey ME, Schanen NC, Zappella M, Renieri A, Huppke P, Percy AK; RettSearch Consortium.. Rett syndrome: revised diagnostic criteria and nomenclature. Ann Neurol. 2010; Dec;68(6):: 944-50. pmid:21154482 PubMed  
  11. Singh J, Santosh P. Key issues in Rett syndrome: emotional, behavioural and autonomic dysregulation (EBAD) - a target for clinical trials. Orphanet J Rare Dis. 2018 Jul 31;13(1):128. doi: 10.1186/s13023-018-0873-8. PMID: 30064458 PubMed  
  12. Banerjee A, Miller MT, Li K, Sur M, Kaufmann WE. Towards a better diagnosis and treatment of Rett syndrome: a model synaptic disorder. Brain. 2019 Feb 1;142(2):239-248. PMID: 30649225 PubMed  
  13. Wink LK1, Fitzpatrick S1, Shaffer R1, Melnyk S1, Begtrup AH1, Fox E1, Schaefer TL1, Mathieu-Frasier L1, Ray B2, Lahiri D2, Horn PA1, Erickson CA1.. The neurobehavioral and molecular phenotype of Angelman Syndrome.. Am J Med Genet A. 2015; Nov;167A(11):: 2623-8. pmid: 26219744 PubMed  
  14. Ramm-Pettersen A1, Selmer KK, Nakken KO.. Glucose transporter protein type 1 (GLUT-1) deficiency syndrome.. Tidsskr Nor Laegeforen. 2011; May 6;131(8):.: 828-31. pmid:21556087 PubMed  
  15. Hainque E1,2, Gras D3, Meneret A1,2, Atencio M2, Luton MP2, Barbier M2, Doulazmi M4, Habarou F5, Ottolenghi C5, Roze E1,2,6, Mochel F7,6,8.. Long-term follow-up in an open-label trial of triheptanoin in GLUT1 deficiency syndrome: a sustained dramatic effect. J Neurol Neurosurg Psychiatry. 2019; 90(11):.: 1291-1293. pmid:30948626 PubMed  
  16. Hao J1, Kelly DI2, Su J1, Pascual JM3.. Clinical Aspects of Glucose Transporter Type 1 Deficiency: Information From a Global Registry. JAMA Neurol. 2017. pmid:28437535 PubMed  
  17. Mochel F1, Hainque E2, Gras D3, Adanyeguh IM4, Caillet S5, Héron B6, Roubertie A7, Kaphan E8, Valabregue R9, Rinaldi D4, Vuillaumier S10, Schiffmann R11, Ottolenghi C12, Hogrel JY13, Servais L14, Roze E2.. Triheptanoin dramatically reduces paroxysmal motor disorder in patients with GLUT1 deficiency. J Neurol Neurosurg Psychiatry. 2015. pmid:26536893 PubMed  
  • Karl Otto Nakken, spesialist i nevrologi, dr med
  • Marit Bjørnvold og Caroline Beate Lund
  • Unn Ljøstad, spesialist i nevrologi, professor PhD
  • Åse Mygland, spesialiost i nevrologi, professor dr med